• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核质穿梭蛋白核转运蛋白α2的沉默促进多形性胶质母细胞瘤细胞周期停滞和凋亡。

Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme.

作者信息

Martinez-Olivera Ramon, Datsi Angeliki, Stallkamp Maren, Köller Manfred, Kohtz Isabelle, Pintea Bogdan, Gousias Konstantinos

机构信息

Department of Neurosurgery and Neurotraumatology, BG University Hospital Bergmannsheil, 44789 Bochum, Germany.

Department of Laboratory for Neurosurgical Research, BG University Hospital Bergmannsheil, 44789 Bochum, Germany.

出版信息

Oncotarget. 2018 Sep 11;9(71):33471-33481. doi: 10.18632/oncotarget.26033.

DOI:10.18632/oncotarget.26033
PMID:30323892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6173355/
Abstract

We have previously shown that the nucleocytoplasmic carrier karyopherin a2 (KPNA2) is overexpressed in glioblastoma multiforme (GBM) whereas its expression is inversely associated with patient prognosis. However, the promoting role of KPNA2 in gliomagenesis is still poorly understood. This study aims to further elucidate this role of KPNA2 in GBM models. From four different tested GBM cell lines, the U87MG showed the highest proliferation, low adherence and outgrowth in 3D clusters as well as the highest expression of KPNA2, all features conferring greater malignant behaviour. Silencing of KPNA2 via siRNA interference in those cells significantly decreased their proliferative capacity ( = 0.001). We further observed both a significant cell cycle phase arrest ( = 0.040) and the promoting of cellular apoptosis ( = 0.016) as well as a strong trend ( = 0.062) for an inhibition of nuclear import of c-Myc. This study confirms that a higher expression of KPNA2 in GBM is associated with a more malignant phenotype also in models. While increased expression of KPNA2 promotes proliferation and survival of GBM tumour cells, silencing of KPNA2 conferred a less malignant behaviour. Our results strongly suggest that silencing of KPNA2 may play an important role in modulation of malignant features of GBM cells.

摘要

我们之前已经表明,核质载体核转运蛋白a2(KPNA2)在多形性胶质母细胞瘤(GBM)中过表达,而其表达与患者预后呈负相关。然而,KPNA2在胶质瘤发生中的促进作用仍知之甚少。本研究旨在进一步阐明KPNA2在GBM模型中的这一作用。在四种不同测试的GBM细胞系中,U87MG表现出最高的增殖能力、低贴壁性以及在三维聚集体中的生长能力,同时KPNA2表达最高,所有这些特征都赋予了更强的恶性行为。通过小干扰RNA(siRNA)干扰在这些细胞中沉默KPNA2,显著降低了它们的增殖能力(P = 0.001)。我们进一步观察到细胞周期阶段显著停滞(P = 0.040)、细胞凋亡增加(P = 0.016)以及c-Myc核输入抑制的强烈趋势(P = 0.062)。本研究证实,在GBM模型中,KPNA2的高表达也与更恶性的表型相关。虽然KPNA2表达增加促进了GBM肿瘤细胞的增殖和存活,但沉默KPNA2则赋予了较低的恶性行为。我们的结果强烈表明,沉默KPNA2可能在调节GBM细胞的恶性特征中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/a13112ad9a86/oncotarget-09-33471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/2a78b25407d2/oncotarget-09-33471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/b8007cffb308/oncotarget-09-33471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/c5b81b36caea/oncotarget-09-33471-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/a13112ad9a86/oncotarget-09-33471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/2a78b25407d2/oncotarget-09-33471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/b8007cffb308/oncotarget-09-33471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/c5b81b36caea/oncotarget-09-33471-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fe/6173355/a13112ad9a86/oncotarget-09-33471-g004.jpg

相似文献

1
Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme.核质穿梭蛋白核转运蛋白α2的沉默促进多形性胶质母细胞瘤细胞周期停滞和凋亡。
Oncotarget. 2018 Sep 11;9(71):33471-33481. doi: 10.18632/oncotarget.26033.
2
Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.核转运受体载体蛋白-α2 促进体外恶性乳腺癌表型。
Oncogene. 2012 Apr 19;31(16):2101-14. doi: 10.1038/onc.2011.403. Epub 2011 Sep 12.
3
Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.沉默 KPNA2 通过阻断 NF-κB 信号通路和 c-Myc 核转位抑制 IL-6 诱导的乳腺癌恶化。
Life Sci. 2020 Jul 15;253:117736. doi: 10.1016/j.lfs.2020.117736. Epub 2020 Apr 30.
4
Oxidative stress mediates nucleocytoplasmic shuttling of KPNA2 via AKT1-CDK1 axis-regulated S62 phosphorylation.氧化应激通过AKT1-CDK1轴调节的S62磷酸化介导KPNA2的核质穿梭。
FASEB Bioadv. 2024 Jul 5;6(8):276-288. doi: 10.1096/fba.2024-00078. eCollection 2024 Aug.
5
KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation.KPNA2在人和小鼠子宫内膜癌中过表达,并促进细胞增殖。
J Pathol. 2014 Oct;234(2):239-52. doi: 10.1002/path.4390. Epub 2014 Jul 30.
6
KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.KPNA2可预测间变性少突星形细胞瘤患者的长期生存率。
J Clin Neurosci. 2014 Oct;21(10):1719-24. doi: 10.1016/j.jocn.2014.01.011. Epub 2014 Jun 11.
7
The emerging roles of KPNA2 in cancer.KPNA2 在癌症中的新兴作用。
Life Sci. 2020 Jan 15;241:117140. doi: 10.1016/j.lfs.2019.117140. Epub 2019 Dec 6.
8
Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.敲低 KPNA2 通过阻断 p53 核转位抑制口腔鳞状细胞癌细胞系中的自噬。
Oncol Rep. 2018 Jul;40(1):179-194. doi: 10.3892/or.2018.6451. Epub 2018 May 17.
9
Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.核孔蛋白α 2 和核孔蛋白β 1 的表达与胃癌的不良预后相关。
Oncology. 2022;100(12):685-695. doi: 10.1159/000526807. Epub 2022 Oct 21.
10
Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.核转运蛋白α2是一种新型的结肠癌预后标志物和潜在治疗靶点。
J Exp Clin Cancer Res. 2015 Dec 1;34:145. doi: 10.1186/s13046-015-0261-3.

引用本文的文献

1
ZNF143 facilitates the growth and migration of glioma cells by regulating KPNA2-mediated Hippo signalling.锌指蛋白 143 通过调控 KPNA2 介导的 Hippo 信号通路促进胶质瘤细胞的生长和迁移。
Sci Rep. 2023 Jul 9;13(1):11097. doi: 10.1038/s41598-023-38158-x.
2
Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma.胶质母细胞瘤中细胞周期阻滞和凋亡的机制
Biomedicines. 2022 Feb 28;10(3):564. doi: 10.3390/biomedicines10030564.
3
Evidence for Quantum Chemical Effects in Receptor-Ligand Binding Between Integrin and Collagen Fragments - A Computational Investigation With an Impact on Tissue Repair, Neurooncolgy and Glycobiology.

本文引用的文献

1
Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.通过对微阵列数据的生物信息学分析揭示胶质瘤和神经胶质瘤发病机制的分子机制。
Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.
2
Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.对原位脑胶质瘤干细胞进行详细的纵向采样,揭示了 Chr7 增益和 Chr10 缺失在原发性肿瘤形成和复发中是反复发生的事件。
Int J Cancer. 2017 Nov 15;141(10):2002-2013. doi: 10.1002/ijc.30887. Epub 2017 Aug 21.
3
Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma.
整合素与胶原蛋白片段之间受体-配体结合中量子化学效应的证据——对组织修复、神经肿瘤学和糖生物学有影响的计算研究
Front Mol Biosci. 2021 Nov 16;8:756701. doi: 10.3389/fmolb.2021.756701. eCollection 2021.
4
Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.基于多组学的KPNA2分析突出了其在肝细胞癌中的多种潜力。
PeerJ. 2021 Sep 21;9:e12197. doi: 10.7717/peerj.12197. eCollection 2021.
5
Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.长链非编码 RNA CTD-2510F5.4 在胃癌中的预后及临床病理意义。
Gastric Cancer. 2019 Jul;22(4):692-704. doi: 10.1007/s10120-018-00911-x. Epub 2018 Dec 17.
核转运蛋白α2的沉默抑制人肝细胞癌的细胞生长和存活。
Oncotarget. 2017 May 30;8(22):36289-36304. doi: 10.18632/oncotarget.16749.
4
Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.核转运蛋白α2在胆管癌中的过表达通过DNA修复蛋白的核转位与不良预后和吉西他滨敏感性相关。
Oncotarget. 2017 Jun 27;8(26):42159-42172. doi: 10.18632/oncotarget.15020.
5
Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.某些实体瘤中KPNA2表达增加的预后价值:一项系统评价和荟萃分析
Oncotarget. 2017 Jan 3;8(1):303-314. doi: 10.18632/oncotarget.13863.
6
Stem cell markers in glioma progression and recurrence.胶质瘤进展和复发中的干细胞标志物
Int J Oncol. 2016 Nov;49(5):1899-1910. doi: 10.3892/ijo.2016.3682. Epub 2016 Sep 6.
7
Importins and exportins as therapeutic targets in cancer.Importins 和 exportins 作为癌症治疗靶点。
Pharmacol Ther. 2016 Aug;164:135-43. doi: 10.1016/j.pharmthera.2016.03.020. Epub 2016 Apr 23.
8
Fascin-1 knock-down of human glioma cells reduces their microvilli/filopodia while improving their susceptibility to lymphocyte-mediated cytotoxicity.Fascin-1 敲低可减少人神经胶质瘤细胞的微绒毛/丝状伪足,同时提高其对淋巴细胞介导的细胞毒性的敏感性。
Am J Transl Res. 2015 Feb 15;7(2):271-84. eCollection 2015.
9
DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.DNA甲基转移酶(DNMT)依赖的微小RNA抑制作用通过Oct4和Sox2调控胶质母细胞瘤肿瘤增殖表型的诱导。
Oncogene. 2015 Jul 23;34(30):3994-4004. doi: 10.1038/onc.2014.334. Epub 2014 Oct 20.
10
KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.KPNA2可预测间变性少突星形细胞瘤患者的长期生存率。
J Clin Neurosci. 2014 Oct;21(10):1719-24. doi: 10.1016/j.jocn.2014.01.011. Epub 2014 Jun 11.